Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about New drug for prostate cancer found promising
Researchers, including one of Indian-origin, have created a new molecule for prostate cancer that has shown great efficacy when tested in mice.The findings suggest that the new therapeutic might be a viable treatment for prostate cancer in humans too if it is found effective the future clinical trials.
- Read more about Vacate interim stay on FDC drugs: Government to HC
The central government on Monday asked the Delhi High Court to vacate the interim stay on ban on some fixed dose combinations (FDC) medicines sold by pharma majors saying they "endanger patient safety".
- Read more about Bedaquiline, solution to tackle drug resistance TB launched
The government on Monday launched Bedaquiline, an exclusive drug to tackle drug resistant TB cases in the country, among several other initiatives against the disease.
- Read more about Will ink accord with WHO to popularise AYUSH globally: Minister
India's AYUSH Minister Sripad Yesso Naik on Sunday said the ministry will ink an agreement with the World Health Organization to popularise AYUSH system of medicine at a global level.

[adsense:336x280:8701650588]
- Read more about Antibiotics can reduce appendicitis surgeries
Using antibiotics as the primary treatment for appendicitis does not increase the risk for complications at least in the first year and can significantly reduce the number of surgeries by 92 percent within the first month of diagnosis, finds a new study.
- Read more about Birth control pill linked to reduced knee injury
Women who take the birth control pill, which lessens and stabilises estrogen levels, are less likely to suffer serious knee injuries, suggests new research.
- Read more about Ketamine abuse can permanently damage your bladder
Researchers have found that ketamine, often abused as a recreational drug, has the potential to damage the bladder permanently and in worst cases it will lead to its removal.
- Read more about FDA approves Bayer's KOVALTRY® antihemophilic factor (Recombinant)
The U.S. Food and Drug Administration has approved Bayer's KOVALTRY® Antihemophilic Factor (Recombinant), an unmodified, full-length factor VIII compound for the treatment of hemophilia A in children and adults. The approval is based on results from the LEOPOLD (Long-Term Efficacy Open-Label Program in Severe Hemophilia A Disease) clinical trials, which supported the approval of KOVALTRY for routine prophylaxis to reduce the frequency of bleeding episodes.
- Read more about Amgen Wins Patent case on repatha® (Evolocumab)
Amgen announced that a Delaware jury delivered a verdict in Amgen's favor in a trial on the validity of two Amgen patents that describe and claim monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9).
- Read more about Chugai receives orphan drug designation for Tocilizumab
Chugai Pharmaceutical Co., Ltd. announced that it received from the Minister of Health, Labour and Welfare, a notification of orphan drug designation for human anti-human IL-6 receptor monoclonal antibody "tocilizumab," a drug under development for treatment of systemic scleroderma.